SynthesisBMC cancer2017

Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.

Dan-Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.